Understanding the human genome has never been more critical for rare disease research and drug development. For pharmaceutical companies and translational research centres, the challenge lies in efficiently interpreting large volumes of genetic data. Whole exome variant analysis allows experts to focus on the coding regions of the genome, highlighting mutations that may contribute to hereditary conditions or multifactorial risk factors.
https://logcla.com/blogs/12534....96/Unlocking-Insight